TP53 and osteosarcoma: Results of co-transfecting wildtype or mutant p53 together with the IGF-1R promotor in an osteosarcoma cell line lacking endogenous p53 suggest that wildtype p53 suppresses the IGF-1R promotor while mutant p53 does not [89].